These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6510224)

  • 21. An expanded profile of cutaneous reactions to nonsteroidal anti-inflammatory drugs. Reports to a specialty-based system for spontaneous reporting of adverse reactions to drugs.
    Stern RS; Bigby M
    JAMA; 1984 Sep; 252(11):1433-7. PubMed ID: 6236306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A zomepirac reaction mimicking ectopic pregnancy.
    Creasy GW; Kousen M; Walker WR
    Drug Intell Clin Pharm; 1984 Jun; 18(6):487-8. PubMed ID: 6734436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zomepirac-induced serum sickness. A report of two cases.
    Kiani R; Kushner M
    JAMA; 1983 May; 249(20):2812-3. PubMed ID: 6842791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zomepirac sodium. A new nonaddicting analgesic.
    Lewis JR
    JAMA; 1981 Jul 24-31; 246(4):377-9. PubMed ID: 7241789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zomepirac and renal failure.
    Ratner SJ
    Ann Intern Med; 1982 Jun; 96(6 Pt 1):793. PubMed ID: 6979965
    [No Abstract]   [Full Text] [Related]  

  • 26. Severe coronary spasm during zomepirac-induced allergic reaction.
    Ahmad S
    South Med J; 1984 Jul; 77(7):938. PubMed ID: 6610944
    [No Abstract]   [Full Text] [Related]  

  • 27. Zomepirac-induced renal failure.
    Miller FC; Schorr WJ; Lacher JW
    Arch Intern Med; 1983 Jun; 143(6):1171-3. PubMed ID: 6222714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anaphylactoid reactions to tolmetin after interrupted dosage.
    Bretza JA; Novey HS
    West J Med; 1985 Jul; 143(1):55-9. PubMed ID: 4036113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Near fatal bronchospasm induced by zomepirac sodium.
    Ross SR; Friedman CJ; Lesnefsky EJ
    Ann Allergy; 1982 Apr; 48(4):233-4. PubMed ID: 7073027
    [No Abstract]   [Full Text] [Related]  

  • 30. Evaluation of the analgesic properties of zomepirac.
    Pruss TP; Gardocki JF; Taylor RJ; Muschek LD
    J Clin Pharmacol; 1980 Apr; 20(4):216-22. PubMed ID: 6247371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Nephrogenic diabetes insipidus possibly secondary to the ingestion of sodium zomepirac dihydrate].
    Llinares Mondéjar P; Sesma Sánchez P; Amador Barciela L; Suárez Sambade D; Martínez Debén F; Agulló García M
    Med Clin (Barc); 1983 Oct; 81(12):546. PubMed ID: 6656373
    [No Abstract]   [Full Text] [Related]  

  • 32. [Anti-inflammatory activity of a non-steroidal anti-inflammatory agent, zomepirac sodium, in experimental animals].
    Nakamura H; Yokoyama Y; Motoyoshi S; Seto Y; Kadokawa T; Shimizu M
    Nihon Yakurigaku Zasshi; 1982 Jun; 79(6):509-27. PubMed ID: 7129241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Zomepirac overdose and review of literature on acute toxicity of nonsteroidal antiinflammatory agents.
    Joubert DW
    Drug Intell Clin Pharm; 1982 Apr; 16(4):328-30. PubMed ID: 6121697
    [No Abstract]   [Full Text] [Related]  

  • 34. Zomepirac: a review of its pharmacological properties and analgesic efficacy.
    Morley PA; Brogden RN; Carmine AA; Heel RC; Speight TM; Avery GS
    Drugs; 1982 Apr; 23(4):250-75. PubMed ID: 7044754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Examining product risk in context: the case of zomepirac.
    Spielberg TE
    JAMA; 1994 Oct; 272(16):1252; author reply 1252-3. PubMed ID: 7933364
    [No Abstract]   [Full Text] [Related]  

  • 36. Tolmetin-induced anaphylactoid reactions.
    Rossi AC; Knapp DE
    N Engl J Med; 1982 Aug; 307(8):499-500. PubMed ID: 7099213
    [No Abstract]   [Full Text] [Related]  

  • 37. Anaphylaxis from tolmetin.
    Ahmad S
    N Engl J Med; 1980 Dec; 303(24):1417. PubMed ID: 7432390
    [No Abstract]   [Full Text] [Related]  

  • 38. Anaphylaxis from tolmetin.
    Restivo C; Paulus HE
    JAMA; 1978 Jul; 240(3):246. PubMed ID: 660851
    [No Abstract]   [Full Text] [Related]  

  • 39. Examining product risk in context. Market withdrawal of zomepirac as a case study.
    Ross-Degnan D; Soumerai SB; Fortess EE; Gurwitz JH
    JAMA; 1993 Oct; 270(16):1937-42. PubMed ID: 8411550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tolmetin anaphylactoid reaction.
    McCall CY; Cooper JW
    JAMA; 1980 Mar; 243(12):1263. PubMed ID: 7359685
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.